title: The increased demand for plasma-derived factor VIII in Italy between 2011 and 2014 is attributable to treatment of adult patients rather than paediatric or previously unexposed patients with severe haemophilia A.
authors.affiliation: The Council of the Italian Association of Haemophilia Centres (AICE), Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Coppola
authors.affiliation: The Council of the Italian Association of Haemophilia Centres (AICE), Italy.
authors.forename: Elena
authors.initials: E
authors.lastname: Santagostino
authors.affiliation: The Council of the Italian Association of Haemophilia Centres (AICE), Italy.
authors.forename: Hamisa J
authors.initials: HJ
authors.lastname: Hassan
authors.affiliation: The Council of the Italian Association of Haemophilia Centres (AICE), Italy.
authors.forename: Angelo C
authors.initials: AC
authors.lastname: Molinari
authors.affiliation: The Council of the Italian Association of Haemophilia Centres (AICE), Italy.
authors.forename: Rita C
authors.initials: RC
authors.lastname: Santoro
authors.affiliation: The Council of the Italian Association of Haemophilia Centres (AICE), Italy.
authors.forename: Annarita
authors.initials: A
authors.lastname: Tagliaferri
authors.affiliation: The Council of the Italian Association of Haemophilia Centres (AICE), Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Morfini
authors.affiliation: The Council of the Italian Association of Haemophilia Centres (AICE), Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Minno
mesh_terms: D000328:Adult; D002648:Child; D005169:Factor VIII; D006467:Hemophilia A; D006801:Humans; D007558:Italy; D010949:Plasma
chemical_list: D005169:Factor VIII